BOLT · Company research

Bolt Biotherapeutics, Inc. (BOLT): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20263.51$5,814,507.74-5794492.2555———223.63491325000000000.29333607832206639088—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.